DEMULEN 1 Drug Patent Profile
✉ Email this page to a colleague
When do Demulen 1 patents expire, and when can generic versions of Demulen 1 launch?
Demulen 1 is a drug marketed by Gd Searle Llc and is included in four NDAs.
The generic ingredient in DEMULEN 1 is ethinyl estradiol; ethynodiol diacetate. There are twenty-six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; ethynodiol diacetate profile page.
